Search Results - "Salzmann, Maren"

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade by Flaig, Thomas W, Salzmann-Sullivan, Maren, Su, Lih-Jen, Zhang, Zhiyong, Joshi, Molishree, Gijón, Miguel A, Kim, Jihye, Arcaroli, John J, Van Bokhoven, Adrie, Lucia, M Scott, La Rosa, Francisco G, Schlaepfer, Isabel R

“…Prostate cancer (PCa) is the most common malignancy among Western men and the second leading-cause of cancer related deaths. For men who develop metastatic…”
Get full text

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions by Joshi, Molishree, Stoykova, Gergana E, Salzmann-Sullivan, Maren, Dzieciatkowska, Monika, Liebman, Lauren N, Deep, Gagan, Schlaepfer, Isabel R

“…Prostate cancer (PCa) is the most common cancer in men, and the global burden of the disease is rising. The majority of PCa deaths are due to metastasis that…”
Get full text

Predictors and Prevalence of Paraganglioma Syndrome Associated With Mutations of the SDHC Gene by Schiavi, Francesca, Boedeker, Carsten C, Bausch, Birke, Peçzkowska, Mariola, Gomez, Clara Fuentes, Strassburg, Thomas, Pawlu, Christian, Buchta, Mary, Salzmann, Maren, Hoffmann, Michael M, Berlis, Ansgar, Brink, Ingo, Cybulla, Markus, Muresan, Mihaela, Walter, Martin A, Forrer, Flavio, Välimäki, Matti, Kawecki, Andrzej, Szutkowski, Zbigniew, Schipper, Jörg, Walz, Martin K, Pigny, Pascal, Bauters, Catherine, Willet-Brozick, Joan E, Baysal, Bora E, Januszewicz, Andrzej, Eng, Charis, Opocher, Giuseppe, Neumann, Hartmut P. H, European-American Paraganglioma Study Group, for the

“…CONTEXT Paraganglioma syndrome includes inherited head and neck paragangliomas (HNPs) and adrenal or extra-adrenal pheochromocytomas and are classified…”
Get full text

Preclinical evaluation of teleglenastat (CB-839) in prostate cancer by Lam, Elaine T., Su, Lih-Jen, Salzmann-Sullivan, Maren, Nordeen, Steven K., Flaig, Thomas W.

“…378 Background: Glutaminase (GLS) levels are upregulated in prostate cancer [PMID: 28138303, 16897757]. The androgen receptor signaling pathway enhances the…”
Get full text

OR34-4 ATF3 Is A Converging Point For AR Signaling And Fatty Acid Oxidation In Prostate Cancer by Joshi, Molishree, Salzmann-Sullivan, Maren, Schlaepfer, Isabel

“…Prostate cancer (PCa) is the second most prevalent cancer and leading causes of death among men worldwide. Androgen deprivation is the first line of treatment…”
Get full text

Abstract A021: CPT1A-mediated fat oxidation and its role in the immune response to prostate cancer by Guth, Amanda M., Salzmann-Sullivan, Maren, Beaton, Camille, Goldkorn, Amir, Gibson, Emily A., Kessler, Elizabeth, Lam, Elaine, Flaig, Thomas, Agarwal, Rajesh, Schlaepfer, Isabel R.

“…Abstract Background and Rationale: While impressive improvements in immunology have led to the identification of immune checkpoint proteins such as CTLA-4 and…”
Get full text

Abstract 1483: Lipid oxidation via CPT1 as a target for prostate cancer imaging and therapy by Schlaepfer, Isabel R., Salzmann-Sullivan, Maren, Su, Lih-Jen, Glode, L.Michael, Flaig, Thomas

“…Abstract Introduction: Prostate cancer (PCa) is the most common cancer in males and is currently treated medically with androgen deprivation therapy. However,…”
Get full text

Abstract 1055: CPT1A-mediated lipid catabolism modulates growth, AR expression and hypoxia survival of prostate cancer by Schlaepfer, Isabel R., Deep, Gagan, Agarwal, Rajesh, Zhang, Zhiyong, Salzmann-Sullivan, Maren, Su, Lih-Jen, Flaig, Thomas

“…Abstract Background: Androgen deprivation results in hypoxia in prostate cancer (PCa) cells and subsequently enhances the transcriptional activity of AR…”
Get full text